Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0699790 (
colon cancer
)
28,837
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The urokinase receptor [urokinase plasminogen activator receptor (u-PAR)] promotes invasion and metastasis and is associated with poor patient survival. Recently, it was shown that Src induces u-
PAR
gene expression via Sp1 bound to the u-
PAR
promoter region -152/-135. However, u-
PAR
is regulated by diverse promoter motifs, among them being an essential activator protein-1 (AP-1) motif at -190/-171. Moreover, an in vivo relevance of Src-induced transcriptional regulators of u-
PAR
-mediated invasion, in particular intravasation, and a relevance in resected patient tumors have not sufficiently been shown. The present study was conducted (a) to investigate if, in particular, AP-1-related transcriptional mediators are required for Src-induced u-
PAR
-gene expression, (b) to show in vivo relevance of AP-1-mediated Src-induced u-
PAR
gene expression for invasion/intravasation and for resected tissues from colorectal cancer patients. Src stimulation of the u-
PAR
promoter deleted for AP-1 region -190/-171 was reduced as compared with the wild-type promoter in cultured
colon cancer
cells. In gelshifts/chromatin immunoprecipitation, Src-transfected SW480 cells showed an increase of phospho-c-Jun, in addition to JunD and Fra-1, bound to region -190/-171. Src-transfected cells showed a significant increase in c-Jun phosphorylated at Ser(73) and also Ser(63), which was paralleled by increased phospho-c-jun-NH(2)-kinase. Significant decreases of invasion/in vivo intravasation (chorionallantoic membrane model) were observed in Src-overexpressing cells treated with Src inhibitors, u-
PAR
-small interfering RNA, and dominant negative c-Jun (TAM67). In resected tissues of 20 colorectal cancer patients, a significant correlation between Src activity, AP-1 complexes bound to u-
PAR
region -190/-171, and advanced pN stage were observed. These data suggest that Src-induced u-
PAR
gene expression and invasion/intravasation in vivo is also mediated via AP-1 region -190/-171, especially bound with c-Jun phosphorylated at Ser(73/63), and that this pathway is biologically relevant for colorectal cancer patients, suggesting therapeutic potential.
...
PMID:Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer. 1751 Mar 14
Extracts from Piptadeniastrum africanum Brenan (Mimosaceae), Petersianthus macrocarpus (Breauv) L. (Lecydaceae), Cissus debilis Planch (Vitaceae) and Dieffenbachia seguine Jacq. (Araceae) were tested in vitro for their antiproliferative activity on human
colon cancer
cell line (CaCo-2). The highest antiproliferative activities were obtained with the alcoholic extracts of the roots of Piptadeniastrum africanum (G-
PAR
), the leaves of Petersianthus macrocarpus (G-PMF) and the stem of Cissus debilis (G-CDL), with 50% inhibition concentrations (IC(50)) of 15 microg/ml, 17 microg/ml and 25 microg/ml respectively. Only one extract (leaves of Dieffenbachia seguine (G-DSF)) exhibited weak antiproliferative activity with 50% inhibition concentration (IC(50)) higher than 50 microg/ml.
...
PMID:Antiproliferative effect of alcoholic extracts of some Gabonese medicinal plants on human colonic cancer cells. 2020 1
u-
PAR
(urokinase-type plasminogen activator receptor), anchored to the cell surface via a glycolipid moiety, drives tumour progression. We previously reported that
colon cancer
cells (RKO clone 2 FS2), attenuated for in vivo tumorigenicity, are diminished >15-fold for u-
PAR
display when compared with their tumorigenic isogenic counterparts (RKO clone 2), this disparity not reflecting altered transcription/mRNA stability. FACS, confocal microscopy and Western blotting using a fused u-
PAR
-EGFP (enhanced green fluorescent protein) cDNA revealed a >14-fold differential in the u-
PAR
-EGFP signal between the isogenic cells, ruling out alternate splicing as a mechanism. Although metabolic labelling indicated similar synthesis rates, pulse-chase revealed accelerated u-
PAR
-EGFP turnover in the RKO clone 2 FS2 cells. Expression in RKO clone 2 cells of a u-
PAR
-EGFP protein unable to accept the glycolipid moiety yielded diminished protein amounts, thus mirroring the low endogenous protein levels evident with RKO clone 2 FS2 cells. Transcript levels for the phosphatidylglycan anchor biosynthesis class B gene required for glycolipid synthesis were reduced by 65% in RKO clone 2 FS2 cells, and forced overexpression in these cells partially restored endogenous u-
PAR
. Thus attenuated u-
PAR
levels probably reflects accelerated turnover triggered by inefficient addition of the glycolipid moiety.
...
PMID:Accelerated urokinase-receptor protein turnover triggered by interference with the addition of the glycolipid anchor. 2114 95
<< Previous
1
2